Ute Hennrich
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 19, 2025
[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 20, 2022
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 28, 2021
Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [18F]PSMA-1007, a PET Tracer for the Imaging of Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 26, 2021
[68Ga]Ga-DOTA-TOC: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 15, 2020
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 01, 2019
Initiation of clinical multicentre studies with local radiotracer production - Regulatory environment and radiopharmaceutical-organisational aspects
Journal: Nuklearmedizin. Nuclear medicine
Published: March 28, 2019
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 20, 2014
BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologies.
Journal: International journal of medical sciences
Published: March 29, 2012
Improved synthesis strategy for peptide nucleic acids (PNA) appropriate for cell-specific fluorescence imaging.
Journal: International journal of medical sciences
Published: October 01, 2011
Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression.
Journal: Bioorganic & medicinal chemistry
Published: July 19, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026